Vanda Pharmaceuticals Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
VNDA on Nasdaq
Location
2200 Pennsylvania Ave Nw, Suite 300 E, Washington, DC

Insiders trading volume in the past year

Vanda Pharmaceuticals Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Mihael H. Polymeropoulos President and CEO, Director, Chairman of the Board $9.69M +$505K +5.49% Aug 7, 2025
Gunther Birznieks SVP, Business Development $1.96M Mar 1, 2025
Kevin Patrick Moran SVP, CFO & Treasurer $1.57M +$8.78K +0.56% Mar 1, 2025
Timothy Williams SVP & General Counsel $1.4M Mar 1, 2025
Joakim Wijkstrom SVP, Chief Marketing Officer $1.14M Mar 1, 2025
Richard W. Dugan Director $701K Jun 5, 2025
Tage Honore Director $488K Jun 5, 2025
Phaedra Chrousos Director $487K Jun 5, 2025
Aranthan Jones II Chief Corp. Affairs Officer $479K Sep 15, 2021
Anne Sempowski Ward Director $470K Jun 5, 2025
Stephen Ray Mitchell Director $446K -$32.1K -6.73% Jun 13, 2025
Thomas Watkins Director $368K Jun 2, 2022

Recent Insider Transactions by Companies or Individuals for Vanda Pharmaceuticals Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.